-
May 10, 2023
Genesis Drug Discovery & Development (GD3), a member of Genesis Global Group, acquires JSS Medical Research to expand its clinical services portfolio.
-
Jan 10, 2023
Genesis Axis Acquires Organochem to Grow the Preclinical Chemistry Services Portfolio.
-
Oct 7, 2021
Genesis Biotechnology Group Acquires BioBlocks to Grow the Preclinical Chemistry Services Portfolio of Genesis Drug Discovery & Development (GD3)
-
Mar 4, 2021
Genesis Drug Discovery and Development acquires Integrated Analytical Solutions to add “off the shelf” PK profiling capabilities to its portfolio
-
Jan 6, 2021
Genesis Drug Discovery and Development expands its presence in the clinical space by acquiring STATKING Clinical Services
-
Dec 9, 2020
Genesis Biotechnology Group announces second year of CRO relationship with Yale University
-
Sep 16, 2020
Genesis Drug Discovery & Development Appoints Laura Sailor Veteran CRO Business Development Leader as Director of Business Development
-
Sep 16, 2020
Genesis Drug Discovery & Development Appoints Anthony Rohr as Chief Operating Officer
-
Sep 16, 2020
Genesis Biotechnology Group Appoints Erich E. Dagnal as Director of Mergers & Acquisitions
-
Aug 5, 2020
Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services
-
Aug 4, 2020
Genesis Drug Discovery & Development (GD3) Announces Appointment of Anthony Rohr, as Chief Executive Officer of PharmOptima
News Read all about us.
got data?
Login
